THA clinicals
Executive Summary
FDA said in a March 24 Talk Paper that the agency "will do everything possible to encourage Dr. Summers not to abandon any of his current patients." FDA has been investigating the researcher's study of THA in 35 patients with Alzheimer's disease, published in the Nov. 13, 1986 issue of The New England Journal of Medicine. "If patients are denied treatment by Dr. Summers, FDA has arranged with Warner-Lambert to set up a special protocol to provide continued treatment," the Talk Paper states.